Alcon Net Profit Margin 2019-2025 | ALC
Current and historical net profit margin for Alcon (ALC) from 2019 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Alcon net profit margin for the three months ending June 30, 2025 was .
| Alcon Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-06-30 | $10.03B | $1.07B | 10.70% |
| 2025-03-31 | $9.93B | $1.12B | 11.28% |
| 2024-12-31 | $9.91B | $1.02B | 10.27% |
| 2024-09-30 | $9.76B | $1.16B | 11.89% |
| 2024-06-30 | $9.64B | $1.10B | 11.44% |
| 2024-03-31 | $9.56B | $1.05B | 10.96% |
| 2023-12-31 | $9.46B | $0.97B | 10.30% |
| 2023-09-30 | $9.27B | $0.45B | 4.85% |
| 2023-06-30 | $9.09B | $0.36B | 3.98% |
| 2023-03-31 | $8.88B | $0.34B | 3.84% |
| 2022-12-31 | $8.72B | $0.34B | 3.84% |
| 2022-09-30 | $8.70B | $0.57B | 6.57% |
| 2022-06-30 | $8.66B | $0.46B | 5.28% |
| 2022-03-31 | $8.55B | $0.46B | 5.38% |
| 2021-12-31 | $8.29B | $0.38B | 4.54% |
| 2021-09-30 | $8.08B | $0.33B | 4.11% |
| 2021-06-30 | $7.82B | $0.18B | 2.34% |
| 2021-03-31 | $6.92B | $-0.39B | -5.63% |
| 2020-12-31 | $6.83B | $-0.53B | -7.77% |
| 2020-09-30 | $6.81B | $-0.72B | -10.53% |
| 2020-06-30 | $6.84B | $-0.64B | -9.30% |
| 2020-03-31 | $7.53B | $-0.60B | -8.03% |
| 2019-12-31 | $7.51B | $-0.66B | -8.74% |
| 2019-06-30 | $5.49B | $-0.71B | -12.86% |
| 2019-03-31 | $5.41B | $-0.30B | -5.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $36.633B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.643B | 25.27 |
| Intuitive Surgical (ISRG) | United States | $196.366B | 76.83 |
| IDEXX Laboratories (IDXX) | United States | $56.993B | 56.60 |
| Edwards Lifesciences (EW) | United States | $47.840B | 32.08 |
| IQVIA Holdings (IQV) | United States | $35.909B | 20.02 |
| Mettler-Toledo (MTD) | United States | $29.655B | 34.41 |
| STERIS (STE) | Ireland | $25.613B | 26.35 |
| DexCom (DXCM) | United States | $22.629B | 31.19 |
| Waters (WAT) | United States | $22.097B | 29.23 |
| Hologic (HOLX) | United States | $16.492B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.914B | 0.00 |
| Penumbra (PEN) | United States | $10.363B | 72.89 |
| Globus Medical (GMED) | United States | $8.334B | 17.33 |
| Masimo (MASI) | United States | $7.726B | 24.76 |
| Sysmex ADR (SSMXY) | Japan | $6.572B | 20.88 |
| Teleflex (TFX) | United States | $4.795B | 7.64 |
| Glaukos (GKOS) | United States | $4.698B | 0.00 |
| TransMedics (TMDX) | United States | $4.271B | 50.60 |
| Veracyte (VCYT) | United States | $3.296B | 37.56 |
| Alphatec Holdings (ATEC) | United States | $2.898B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.707B | 14.62 |
| Integer Holdings (ITGR) | United States | $2.335B | 10.96 |
| Artivion (AORT) | United States | $2.241B | 103.26 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 23.58 |
| PROCEPT BioRobotics (PRCT) | United States | $1.741B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.710B | 16.57 |
| AxoGen (AXGN) | United States | $1.106B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.102B | 0.00 |
| IRadimed (IRMD) | United States | $1.076B | 51.28 |
| Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.901B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.874B | 4.73 |
| SiBone (SIBN) | United States | $0.655B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.580B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.535B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 31.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.519B | 10.35 |
| ClearPoint Neuro (CLPT) | United States | $0.518B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.483B | 0.00 |
| NeuroPace (NPCE) | United States | $0.426B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.415B | 3.26 |
| Mesa Laboratories (MLAB) | United States | $0.412B | 11.41 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.394B | 0.00 |
| RxSight (RXST) | United States | $0.354B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.323B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| 908 Devices (MASS) | United States | $0.280B | 0.00 |
| CVRx (CVRX) | United States | $0.263B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Neuronetics (STIM) | United States | $0.173B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.122B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.082B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.039B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.68 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |